Evidence map›Paper›PMID 33462610›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2021

Waning Vaccine Effectiveness Against Influenza-Associated Hospitalizations Among Adults, 2015-2016 to 2018-2019, United States Hospitalized Adult Influenza Vaccine Effectiveness Network.

Jill M Ferdinands, Manjusha Gaglani, Emily T Martin, Arnold S Monto, Donald Middleton, Fernanda Silveira, H Keipp Talbot, Richard Zimmerman, Manish Patel

Open access · hybridAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 3 pooled it
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 3 syntheses or guidelines pooled it, 56 citations in OpenAlex.

  1. Guideline
  2. Guideline
  3. Guideline
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Vaccine Effectiveness Against Influenza A-Associated Hospitalization, Organ Failure, and Death: United States, 2022-2023.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Jill M FerdinandsInfluenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Manjusha GaglaniBaylor Scott & White Health System, Temple, Texas, USA.
Emily T MartinUniversity of Michigan School of Public Health, Ann Arbor, Michigan, USA.
Arnold S MontoUniversity of Michigan School of Public Health, Ann Arbor, Michigan, USA.
Donald MiddletonUniversity of Pittsburgh and University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
Fernanda SilveiraUniversity of Pittsburgh and University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
H Keipp TalbotVanderbilt University Medical Center, Nashville, Tennessee, USA.
Richard ZimmermanUniversity of Pittsburgh and University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
Manish PatelInfluenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
University of Pittsburgh Medical Center · USCenters for Disease Control and Prevention · USUniversity of Michigan–Ann Arbor · USBaylor Scott & White Health · USVanderbilt University Medical Center · US

Funding

Vanderbilt Institute for Clinical and Translational Research (VICTR) -Identifying correlates of functional immunity in SARS-CoV-2 convalescent plasmaUL1TR002243 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Paul A. Harris, Wesley H Self · 2017 to 2026
$130.7M
University of Pittsburgh Clinical and Translational Science InstituteUL1TR001857 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2016 to 2025
$129.3M
Flu vaccine effectiveness in thosehospitalized in a large diverse health systemU01IP000969 · IP · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ZIMMERMAN, RICHARD K · 2015 to 2019
$4.5M
US Hospital Vaccine Effectiveness (VE) Network - SupplementU01IP000974 · IP · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MONTO, ARNOLD S · 2015 to 2019
$4.5M
Core_Apt Measure of PCR-based Influenza Vaccine Effectiveness in Inpatient AdultsU01IP000972 · IP · SCOTT AND WHITE MEMORIAL HOSPITAL · PI GAGLANI, MANJUSHA · 2015 to 2019
$3.5M
CDC HHSNCATS NIH HHS UL1 TR001857NCATS NIH HHS UL1 TR002243NCIRD CDC HHS U01 IP000969NCIRD CDC HHS U01 IP000972NCIRD CDC HHS U01 IP000974NIH HHS UL1 TR001857
6 · The paper itself

Abstract

We observed decreased effectiveness of influenza vaccine with increasing time since vaccination for prevention of influenza A(H3N2), influenza A(H1N1)pdm09, and influenza B/Yamagata-associated hospitalizations among adults. Maximum vaccine effectiveness (VE) was observed shortly after vaccination, followed by an absolute decline in VE of about 8%-9% per month postvaccination.

Indexed as

Influenza A Virus, H1N1 SubtypeInfluenza, HumanInfluenza VaccinesAdultHospitalizationHumansInfluenza A Virus, H3N2 SubtypeUnited StatesInfluenza Vaccinesadultshospitalizationinfluenzavaccine effectivenesswaning

Identifiers

PMID33462610
PMCPMC8499703
OpenAlexW3122314944

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.